Latest news
FDA PDUFA Watch: Neurology Decisions to Track Through Late September - NeurologyLiveNeurologyLive · Thu, 06 Aug 2026 14:15:45 GMTXspray Pharma (Q2 review): Just ahead of Dasynoc PDUFA - TradingViewTradingView · Thu, 06 Aug 2026 10:44:00 GMTPraxis Precision Medicines posts investor deck highlighting late-stage CNS pipeline, upcoming PDUFA dates - BitgetBitget · Thu, 06 Aug 2026 04:37:33 GMTSavara: High-Potential Binary Bet Cruising To PDUFA After A 3 Month Speed Bump (SVRA) - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 10:25:03 GMTFDA Accepts SL1009 Resubmission for PDCD, Sets December PDUFA Date - NeurologyLiveNeurologyLive · Tue, 04 Aug 2026 23:15:37 GMTFDA unveils FY 2027 user fee rates - RAPSRAPS · Thu, 30 Jul 2026 07:00:00 GMTDyne Therapeutics reports Q2 net loss $178.6M, cash $898.5M; BLA for z-rostudirsen accepted with PDUFA Jan 21, 2027 - TradingViewTradingView · Wed, 29 Jul 2026 20:43:04 GMTHansa Biopharma (Q2 Review): SERB Deal Closed, December PDUFA Supported by Data - TradingViewTradingView · Tue, 28 Jul 2026 16:18:00 GMT